Acute Respiratory Failure: Clinical Trials

4 trials for Acute Respiratory Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 21Terminated 1

Follow Acute Respiratory Failure: new trials by email Literature Review of Acute Respiratory Failure trials Research Report on Acute Respiratory Failure

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
IV Ganciclovir, Normal saline - Acute Respiratory Failure
Phase 3TerminatedFred Hutchinson Cancer Center2052021-06-292026-10-20
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
Hyperbaric oxygen - SARS (Severe Acute Respiratory Syndrome), Cytokine Storm
Phase 2 / Phase 3TerminatedKarolinska Institutet342020-06-032023-01-09
ARrest RESpiraTory Failure From PNEUMONIA
Inhaled budesonide and formoterol, Inhaled placebo - Pneumonia, Hypoxemia
Phase 3TerminatedStanford University4652020-06-012026-08-06
Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
Olimel (5.7%E / N9E) - Critical Illness, Acute Respiratory Failure
Phase 3TerminatedClinical Evaluation Research Unit at Kingston General Hospital1252011-06-012021-03-16

Narrower conditions

COVID-19 (1)  ·  Critical Illness (1)  ·  Cytokine Release Syndrome (1)  ·  Hypoxia (1)  ·  Pneumonia (1)  ·  Respiratory Distress Syndrome (1)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)  ·  Inflammation (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiration Disorders (1)

Interventions

Budesonide (1)  ·  Formoterol Fumarate (1)  ·  Ganciclovir (1)  ·  Hyperbaric Oxygenation (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Clinical Evaluation Research Unit at Kingston General Hospital (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Karolinska Institutet (1)  ·  Stanford University (1)

Countries

United States (3)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Anders Kjellberg, MD (1)  ·  Daren K. Heyland, MD (1)  ·  Emir Festic, MD (1)  ·  Joseph Levitt, MD (1)  ·  Kenny Rodriguez-Wallberg, MD, PhD (1)  ·  Michael Boeckh, MD (1)  ·  Peter Lindholm, MD, PhD (1)

Results publications

PMID 28599676, PMID 32738928, PMID 33493423, PMID 34226219, PMID 37510965, PMID 39393522

NIH funding

1UG3HL141722-01A1 (1), 1UG3HL147011-01A1 (1)